Lantheus Holdings recently received FDA approval for PYLARIFY TruVu, an enhanced formulation of its PSMA PET imaging agent designed to improve manufacturing efficiency and geographic reach for ...

Humour-led campaign invites men to share the nickname they use for their penis to spark conversations about penile cancer ...

Monte Rosa Therapeutics Inc. reports fourth-quarter and full-year 2025 results Thursday, closing out a year marked by promising clinical data but facing investors’ questions about revenue ...

The S&P/ASX 200 closed 93.6 points higher, up 1.09%.

Investing.com-- Shares of Telix Pharmaceuticals (ASX:TLX) jumped on Tuesday after the company reported positive results from ...

Tommy DeCarlo, a singer who went from posting covers on MySpace to touring as Boston's lead vocalist for years, has died at ...

Monte Rosa Therapeutics recently reported updated Phase 1/2 data showing that its investigational GSPT1 degrader MRT-2359, in combination with enzalutamide, was well-tolerated and produced positive ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...

Bayer (XTRA:BAYN) has received preliminary US court approval for a multibillion-dollar class action settlement tied to Monsanto's Roundup weedkiller. The proposed agreement is intended to address tens ...

Johnson & Johnson (NYSE:JNJ) received FDA Fast Track designation for nipocalimab as a potential treatment for systemic lupus erythematosus, supported by positive Phase 2 data and the start of a Phase ...